Secondary
Seattle Genetics
They are a biotechnology company focused on the development and commercialization of targeted therapies for the treatment of cancer.
Symbol
SGEN
Last Closing Price
$52.30
Effective Date
February 1, 2018
Underwriters
Barclays, J.P. Morgan
To view the prospectus for Seattle Genetics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277